Analysis of hydration and antiemetics policies in preventing cisplatin-related gastrointestinal and renal toxicities in low-risk human papillomavirus positive-oropharyngeal cancer (HPV plus OPC) patients undergoing chemoradiation in De-ESCALaTE trial.
Kong AH., Mistry P., Evans M., Hartley AGJ., Fulton-Lieuw T., Jones D., Dalby M., Gray A., Foran B., Sen M., O'Toole L., Al-Booz H., Dyker K., Mancebo RM., Whittaker S., Brennan SM., Cook A., Griffin M., Dunn J., Mehanna HM.